How Real Patient Experiences Can Make a Difference in the Fight Against Alzheimer’s
By
the PicnicHealth team
on
May 24, 2022
January 6, 2022
/
4
minute read
It’s an exciting time for Alzheimer’s disease research. The FDA approved the first new drug for Alzheimer’s in nearly 20 years in June 2021, and other potential treatments, targeting amyloid plaques in the brain, are making their way through clinical trials.1, 2 It’s a glimmer of hope for Alzheimer’s patients, who number over 6 million in the U.S. alone.
